ABBOTT PARK, Ill., Oct. 28, 2022 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, named Abbott's FreeStyle Libre ® continuous ...

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...

Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the ...

Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system ...

Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce ...

ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud ...

Abbott has now identified the manufacturing issue that caused the fault in the sensors used in its FreeStyle Libre 3 and Libre 3 Plus CGMs. Image credit: Jonathan Weiss via Shutterstock.com. Abbott ...

Check out the latest Abbott Laboratories (ABT) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least ...

Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now. Following encouraging results from ...